January 20, 2021
Shionogi is seeking to introduce a continuous manufacturing method for the production of its anti-flu drug Xofluza (baloxavir marboxil) in Japan. The company has filed an application with Japanese regulatory authorities, aiming to tweak the currently approved production process to...read more